Welcome Guest
Sign In
Register
Home
Bioprocessing
Chromatography
Drug Delivery
Excipients
Formulation Development
Microbiology
Spectroscopy
Articles
Issue Archives
Whitepapers / App Notes / eBooks
Industry Expert
Facility Tour
CGT Circuit
News
Products
Featured Products
New Products
Analytical Equipment
Formulation Development
Pharmaceutical Manufacturing
Excipients
All Other Products
QC Corner
Webinars
Videos
A Solid Dosage Future Documentary
Clean Facility Documentary
Continuous Processing Documentary
Cell and Gene Therapy Documentary
Making Data Work Documentary
Company Profiles
Events
Register
Sign In
Home
Product Center
Pharmaceutical Excipients
Excipients
Excipients
Your search returned 40 Excipient Search across 1 supplier.
Showing 40 of 40 products
<<
<
>
>>
Sort By
Item Name
Company Name
Price
Relevancy
Select All
Select up to 5 products from below to compare or request more information.
Compare
Sponsored Products
Geloil™ SC
Gattefossé
Functionality:
Vehicle to suspend actives and ingredients in high solid content capsules
Application:
Ready-to-use suspending vehicle for hard or soft gelatin capsule filling
Get quote
Compare
or
Get quote
for selected.
Maisine® CC
Gattefossé
Functionality:
Oily vehicle solubilizer and bioavailability enhancer for lipophilic APIs, associated with lymphatic absorption, oily vehicle for topical formulations
Application:
Oral, Topical
Get quote
Compare
or
Get quote
for selected.
Labrasol® ALF
Gattefossé
Functionality:
Water disperible surfactant, solubilizer and bioavailability enhancer in SMEDDS, topical penetration/permeation enhancer, able to form light foams with pump device (no gas required), low impurities guaranteed for stability and capsule compatibility
Application:
Oral, Topical, Transdermal
Get quote
Compare
or
Get quote
for selected.
Compritol® 888 ATO
Gattefossé
Functionality:
Lubricant for capsules and tablets, coating for protection and taste masking, lipid matrix for sustained release and SLN/NLC, viscosity modification
Application:
Lipidic matrix for sustained release and SLN/NLC, coating agent for taste masking, lubricant for tablets and capsules, texture enhancer for topicals
Get quote
Compare
or
Get quote
for selected.
Labrafac™ MC60
Gattefossé
Functionality:
Solubilizer, bioavailability enhancer, co-surfactant, and penetration/permeation enhancer for SMEDDS and topicals
Application:
Oral, Topical
Get quote
Compare
or
Get quote
for selected.
Transcutol® HP
Gattefossé
Functionality:
High purity solvent for all types of dosage forms, capsules, injectables, co-solvent in SMEDDS, solutions, suspensions, topical penetration and permeation enhancer
Application:
Oral, Topical, Transdermal, Parenteral
Get quote
Compare
or
Get quote
for selected.
Monosteol™
Gattefossé
Functionality:
Consistency agent for oily phase in topical formulations. Stability-improving agent
Application:
Non-ionic consistency/thickening agent, Stabilizer for emulsions
Get quote
Compare
or
Get quote
for selected.
Compritol® HD5 ATO
Gattefossé
Functionality:
Lubricant and wetting agent in fast-dissolving and effervescent tablets
Application:
Oral
Get quote
Compare
or
Get quote
for selected.
Labrafac™ PG
Gattefossé
Functionality:
Oily phase vehicle and solubilizer
Application:
Oral, Topical
Get quote
Compare
or
Get quote
for selected.
Ovucire® 3460
Gattefossé
Functionality:
Good mechanical resistance. Enhanced spreadability of the formulation for vaginal delivery.
Application:
Unique blends with varying consistency and wetting properties adapted for vaginal pessaries
Get quote
Compare
or
Get quote
for selected.
Ovucire® WL 3264
Gattefossé
Functionality:
Enables fast-melting at normal temperature of the vaginal cavity.
Application:
Unique blends with varying consistency and wetting properties adapted for vaginal pessaries
Get quote
Compare
or
Get quote
for selected.
Suppocire® Series
Gattefossé
Functionality:
Range of bases for rectal/ vaginal suppositories with varying melting points and additives to vary consistency and wetting properties
Application:
Rectal/Vaginal
Get quote
Compare
or
Get quote
for selected.
Ovucire® series
Gattefossé
Functionality:
Unique blends with varying consistency and wetting properties adapted for vaginal pessaries, enables fast-melting
Application:
Rectal/Vaginal
Get quote
Compare
or
Get quote
for selected.
Emulcire ™ 61 WL 2659
Gattefossé
Functionality:
Co-emulsifing base for topical dosage forms
Application:
Topical
Get quote
Compare
or
Get quote
for selected.
Emulfree ™ DUO
Gattefossé
Functionality:
Ready-to-use stabilizer for O/W bi-gel systems
Application:
Topical
Get quote
Compare
or
Get quote
for selected.
Capryol PGMC
Gattefossé
Functionality:
Solubilizer, bioavailability and penetration enhancer, water insoluble W/O cosurfactant for SELF and suspensions
Application:
Oral, Topical
Get quote
Compare
or
Get quote
for selected.
Plurol® Oleique CC 497
Gattefossé
Functionality:
Solubilizer and bioavailability enhancer for poorly-soluble APIs, cosurfactant in microemulsions, viscosity enhancer for capsule filling
Application:
Oral, Topical
Get quote
Compare
or
Get quote
for selected.
Tefose® 1500
Gattefossé
Functionality:
Non-ionic O/W emulsifier, low-energy one-pot processing, high mucosal tolerance
Application:
Topical, Rectal/Vaginal
Get quote
Compare
or
Get quote
for selected.
Gelot™ 64
Gattefossé
Functionality:
Emulsifier for difficult-to-formulate APIs, API combinations, and anhydrous emulsions, enhances sensorial and texture properties when associated with Emulcire™ 61 WL2659
Application:
Topical
Get quote
Compare
or
Get quote
for selected.
Gelucire® 43/01
Gattefossé
Functionality:
Matrix-forming agent for protection of APIs sensitive to oxidation, humidity, or light, consistency agent in oral and topical formulations
Application:
Oral, Topical
Get quote
Compare
or
Get quote
for selected.
Sedefos™ 75
Gattefossé
Functionality:
Emulsifier for anhydrous topical formulations. Emulsifier for difficult-to-formulate emulsions (solvents and large oily phase). Stabilizes and improves sensorial and texture properties.
Application:
Inquire
Get quote
Compare
or
Get quote
for selected.
Gelucire® 44/14
Gattefossé
Functionality:
Solubilizer, bioavailability enhancer, and surfactant in solid dispersions and SMEDDS
Application:
Oral
Get quote
Compare
or
Get quote
for selected.
Gelucire® 50/13
Gattefossé
Functionality:
Solubilizer, bioavailability enhancer, and surfactant for poorly-soluble APIs in solid dispersions and SMEDDS, lipid binder in melt processes
Application:
Oral
Get quote
Compare
or
Get quote
for selected.
Labrafac™ lipophile WL 1349
Gattefossé
Functionality:
Oily phase vehicle and solubilizer
Application:
Oral, Topical, Rectal/Vaginal, Transdermal, Nasal, Parenteral
Get quote
Compare
or
Get quote
for selected.
Lauroglycol™ FCC
Gattefossé
Functionality:
Solubilizer, bioavailability and penetration enhancer, water insoluble W/O co-surfactant for SELF and suspensions
Application:
Oral, Topical, Transdermal
Get quote
Compare
or
Get quote
for selected.
Peceol™
Gattefossé
Functionality:
Oily vehicle solubilizer and bioavailability enhancer for lipophilic APIs, associated with lymphatic absorption, oily vehicle for topical formulations
Application:
Oral, Topical
Get quote
Compare
or
Get quote
for selected.
Tefose® 63
Gattefossé
Functionality:
Non-ionic O/W emulsifier, low-energy one-pot processing, high mucosal tolerance
Application:
Topical, Rectal/Vaginal
Get quote
Compare
or
Get quote
for selected.
Transcutol® P
Gattefossé
Functionality:
High purity solvent, topical penetration and permeation enhancer, co-solvent in SMEDDS, solutions, suspensions
Application:
Oral, Topical, Transdermal, Parenteral
Get quote
Compare
or
Get quote
for selected.
Gelucire® 59/14
Gattefossé
Functionality:
Solubilizer, bioavailability enhancer, and surfactant in solid dispersions and SMEDDS
Application:
Oral
Get quote
Compare
or
Get quote
for selected.
Capryol™90
Gattefossé
Functionality:
Solubilizer, bioavailability and penetration enhancer, water insoluble W/O cosurfactant for SELF and suspensions
Application:
Oral, Topical, Transdermal, Parenteral
Get quote
Compare
or
Get quote
for selected.
Geleol™ Mono and Diglycerides NF
Gattefossé
Functionality:
Modified release matrix former for capsules, coating agent for taste masking, consistency agent
Application:
Oral, Topical, Rectal/Vaginal
Get quote
Compare
or
Get quote
for selected.
Gelucire® 48/16
Gattefossé
Functionality:
Solubilizer, bioavailability enhancer, and surfactant for poorly-soluble APIs, solid dispersions, and SMEDDS
Application:
Oral
Get quote
Compare
or
Get quote
for selected.
Labrafil® M 2125 CS
Gattefossé
Functionality:
Solubilizer and bioavailability enhancer for poorly-soluble APIs, self-emulsifier in aqueous fluid
Application:
Oral, Topical, Rectal/Vaginal, Transdermal, Nasal, Parenteral
Get quote
Compare
or
Get quote
for selected.
LauroglycolTM 90
Gattefossé
Functionality:
Solubilizer, bioavailability and penetration enhancer, water insoluble W/O co-surfactant for SELF and suspensions
Application:
Oral, Topical, Transdermal
Get quote
Compare
or
Get quote
for selected.
Plurol® Diisostearique
Gattefossé
Functionality:
PEG-free W/O emulsifier for hot or cold process topical formulations, ideal for heat-sensitive APIs, stabilizes and improves sensorial and texture properties, excellent for dispersions and apolar oils
Application:
Topical
Get quote
Compare
or
Get quote
for selected.
Labrasol®
Gattefossé
Functionality:
Solubilizer and O/W surfactant for microemulsion. Able to form light foams with pump device (no gas required).
Application:
Water dispersible surfactant, Solubilizer, Bioavailability enhancer, Component of SELF, Topical penetration/permeation enhancer
Get quote
Compare
or
Get quote
for selected.
Labrafil® M1944 CS
Gattefossé
Functionality:
Solubilizer, Bioavailability enhancer, Surfactant in capsule filling, SMEDDS, Solutions, Suspensions, Injectables, Topical Penetration and Permeation enhancer
Application:
Solubilizer, Bioavailability enhancer, Surfactant in capsule filling, SMEDDS, Solutions, Suspensions, Injectables, Topical Penetration and Permeation enhancer
Get quote
Compare
or
Get quote
for selected.
Labrasol®
Gattefossé
Functionality:
Solubilizer, Bioavailability enhancer, Surfactant in capsule filling, SMEDDS, Solutions, Suspensions, Topical Penetration and Permeation enhancer, Processing aid
Application:
Solubilizer, Bioavailability enhancer, Surfactant in capsule filling, SMEDDS, Solutions, Suspensions, Topical Penetration and Permeation enhancer, Processing aid
Get quote
Compare
or
Get quote
for selected.
Labrafil® M 1944 CS
Gattefossé
Functionality:
Solubilizer and bioavailability enhancer for poorly-soluble APIs, self-emulsifier in aqueous fluid, co-emulsifier in topical formulations often associated with Tefose® 63
Application:
Oral, Topical, Rectal/Vaginal, Transdermal, Nasal, Parenteral
Get quote
Compare
or
Get quote
for selected.
Precirol® ATO 5
Gattefossé
Functionality:
Lubricant for capsules , coating for protection and taste masking, lipid matrix for sustained release and SLN/NLC, viscosity modification
Application:
Oral, Topical
Get quote
Compare
or
Get quote
for selected.
Select All
Select up to 5 products from above to compare or request more information.
Compare
Tags:
Please Login or Register to Create Tags
Feedback
Articles
FlowLac® 90
Klucel™ exf ultra hpc
DuraLac® H
gelwoRx™ Dsolve portfolio
VIVACOAT® ocean-pure
CEOLUS PH Grade Microcrystalline Cellulose
Miniaturized Equipment for Early Formulation Development
Why is GMP Training a Necessity at Excipient Sites?
Using Process Analytical Technologies for Real Time Monitoring and Quality Assurance in Chemical Development
Functionality and Performance of Excipients in Quality-by-Design World, Part VIII: Excipient Specifications
Functionality and Performance of Excipients in Quality-by-Design World Part V: Changes in the Sourcing and Supply of Pharmaceutical Excipients
The Impact of USP’s New Elemental Impurities Standards on Manufacturers, Suppliers and Contract Laboratories
Development of Freeze-dried Formulations Using Thermal Analysis and Microscopy
Ion Chromatography in USP-NF
Davisco Foods International, Inc. and Meggle Group announce a Joint Venture for the Production of Pharmaceutical Lactose
An Update on Oral Administration of Peptides to Achieve Systemic Delivery
Principles of Drug Design: How to Leverage Ligand-Receptor Molecular Interactions
Precision Medicine in Clinical Trials: A Statistical Perspective
Gattefossé North America Announces Recipient of 2017 Award for Excellence
Controlled Release Pulmonary Therapies: Promises and Concerns
FDA Finalizes Bulk Drug substances Rule
Process Validation and Sterility Assurance: Relations and Requirements
Captisol® Modified Cyclodextrin
Quality-by-Design for Freeze-Thaw of Biologics: Concepts and Application to Bottles of Drug Substance
Parenteral Products: Pharmacopeial Control of Containers, Storage and Distribution
Hot-stage Optical Microscopy as an Analytical Tool to Understand Solid-state Changes in Pharmaceutical Materials
The Lifecycle of Drugs from Development to Approval and Market Launch
Moving Towards Genome Integrity Evaluation of Gene Therapy Viral Vectors
CEOLUS UF Grade Microcrystalline Cellulose
Understanding and Resolving Drug Shortages in the Pharmaceutical Industry
VIVACOAT® A - Ready-to-Use Coating System
Polyplasdone™ Plus Multifunctional Disintegrant
Apinovex™ Polymers
Pearlitol 200SD
VIVACOAT® seal
Enhancing Formulation Development: Leveraging Specialty Chemicals for Improved Drug Delivery
Tracking Host Cell Proteins During Biopharmaceutical Manufacturing: Advanced Methodologies to Ensure High Product Quality
ABITEC Launches New Versatile Excipient for Oral Dosage Applications
An Interview with DSM
Aptalis Pharmaceutical Technologies Sponsors 2012 Controlled Release Society’s Young Investigator Award at Annual Meeting and Exposition
New VitalDose® Blog Debuts
Catalent Announces Commencement of Supply of Abilify® Orally Disintegrating Tablets to Otsuka Pharmaceutical Co. Ltd. and Extensive Investments to it's Zydis® to Technology Capabilities in Swindon, UK
Use of Enzymes in the Dissolution Testing of Gelatin Capsules
CPhI Announces USA Market Report at InformEx
Klucel™ xtend Hydroxypropylcellulose (HPC) Controlled Release Matrix Former
Benecel™ xrf hpc
BASF Starts Up tert. Butylamine plant in Nanjing, China
A Discourse on Pharmaceutical cGMP FDA Form 483 Trends: Why are We Re-Living the Same Issues Over the Last 23 Years?
The CDMO’s Challenges for Developing Oral Suspensions for Children
Particle Size Specifications for Solid Oral Dosage Forms: A Regulatory Perspective
Amorphous Solid Dispersions as Enabling Formulations for Discovery and Early Development
Compendial Standards and Excipient Performance in the QbD Era: USP Excipient Performance Chapter <1059>
Aesica Appoints Ian Muir to Newly Created Commercial Managing Director Position
Labrasol® ALF
Maisine® CC
Pharmaceutical P.I.N. Points: Patent Innovation News - March 2023
CEOLUS KG Grade Microcrystalline Cellulose
Keeping Patients in Focus: Limiting Treatment Burden for Improved Eye Care
Pharmaceutical P.I.N. Points: Patent Innovation News - April 2023
Application Challenges and Examples of New Excipients in Advanced Drug Delivery Systems
Evaluation of In-Situ Fiber Optics Dissolution Method for Compound A Extended Release Tablets
Advances in Lipid-based Formulations: Overcoming the Challenge of Low Bioavailability for Poorly Water Soluble Drug Compounds
Lubrizol Invests $60 Million to Expand Particle Sciences, Vesta and Other Facilities in 2017
CPhI opens Awards to Global Pharma Industry, Celebrating Tomorrow’s Innovations Today
CPhI Report Indicates a Need for Greater Third Party Certification to Ensure GMP Vigilance
An Interview With Shaukat Ali, PhD
Facility Tour: Gattefossé - The Lipid Chemistry Experts
Mechanism of Stabilization of Proteins by Poly-hydroxy Co-solvents: Concepts and Implications in Formulation Development
Effective Formulation Development Strategies for Poorly Soluble Active Pharmaceutical Ingredients (APIs)
Stability Testing – Doing Everything or Doing the Right Thing?
Functionality and Performance of Excipients in a Quality-by-Design World Part X: Continuous Processing of Pharmaceutical Finished Products
Functionality and Performance of Excipients in Quality-by-Design World, Part VII: Quality Risk Management
An Interview with Meggle
BASF Extends Offer Period for Pronova BioPharma
Solid Lipid Nanocarrier Development Toolbox for Increasing Oral Bioavailability of API
An Interview With Jasmine Musakhanian, M.Sc. Marketing & Scientific Director of Pharmaceutical Division Gattefossé USA
CELPHERE MCC Spherical Seed Core
Soluplus
Actimask® Acetaminophen 92M
Aquarius™ TF Film Coating System
Pearlitol 200GT
VIVACOAT® free
Aclar® Crystal-clear Barrier Films
Carbopol® Polymers
ABITEC, UNIVAR Canada Announce Specialty Lipid Distribution Agreement
Aquarius™ Genesis Film Coating System
In Vitro
High-throughput Drug Precipitation Methods for Oral Formulations
Functionality and Performance of Excipients in a Quality-by-Design World, Part IX: New Excipients
Functionality and Performance of Excipients in Quality-by-Design World Part VI: Excipient Composition
An Interview with DSM
BASF Increases Cash Offer for Pronova BioPharma
The Innovator Pipeline: Bioavailability Challenges and Advanced Oral Drug Delivery Opportunities
The Creation of an Excipient Properties Database to Support Quality by Design (QbD) Formulation Development
Case Study: LUBRITAB® RBW Direct Compression Tableting
World’s First Triple Compound: CombiLac® from Meggle
Micromeritics to Participate in University of Maryland Tableting Course
Catalent Announces Two Senior Executive Appointments to Support Global Development and Clinical Services Business Growth
Permeation Enhancer Excipients
Wet Granulation Excipients
Trends and Innovations in Oral Drug Delivery Round Table
Microbiologics Announces New CEO
Effervescent Excipients
Solubility Enhancement Excipients
Binder Excipients
Taste Masking Excipients
Coating Systems Excipients
Active Pharmaceutical Ingredient Excipients
Carrier Excipients
Direct Compression Excipients
Solvent Excipients
Granulation Excipients
CPhI Japan 2014: Japanese Market to Continue to Dominate Global Pharma
BASF Received EXCiPACTTM Certification as Pharmaceutical Excipient Supplier
BASF to Build New World-scale Plant for Specialty Amines in Ludwigshafen
Lipids in Transdermal and Topical Drug Delivery
CPhI Pharma Awards Winners Showcase the Innovations Driving Pharma
Chris Kilbee Appointed Group Director of UBM Pharma Portfolio
Viscosity Modifier Excipients
Dry Powder Inhalation Excipients
Emulsifier Excipients
Co-processed Excipients
Diluent Excipients
Sweetener Excipients
Lubricant Excipients
Natural Origin Excipients
Capsule Filling Excipients
Film Excipients
Multifunctional Excipients
Thermo Fisher Scientific Receives Clearance from the European Commission for its Acquisition of Life Technologies
Stabilizer Excipients
Surfactant Excipients
Plasticizer Excipients
Disintegrant Excipients
Effervescent System Excipients
Rapid Release Agent Excipients
Controlled Release Excipients
Increased Bioavailability Excipients
Tablet Compressibility Excipients
Powder Excipients
Dispersion Excipients
Whitepaper: VOC Reducing Additives for Masterbatches and Final Polymer Articles
Natoli Debuts New Website
Almac Doubles Global 2-8°C Cold Room Capacity in Response to Increasing Biologics Demand
Noramco, SPI Pharma Announce Availability of Excipient Compatibility Study for Cannabidiol Solid Oral Dosage Forms
Compaction Excipients
Penetration Enhancer Excipients
Dry Granulation Excipients
Roundtable: Excipient Trends/Challenges
Hydroxypropyl Cellulose for Orally Disintegrating Film Drug Application
First GMP-Compliant Batch of a Biologic Drug Substance from a Moss Expression System Produced for Clinical Use
BASF and Colorcon Cooperate on Kollicoat
®
IR for Ready-to-Use Pharmaceutical Coating Solutions
Croda Celebrates EXCiPACTTM “Double”
Pharmaceutical Excipients Identification With Handheld Raman
Catalent Pharma Solutions and Adamas Pharmaceuticals Enter Into Phase 3 Clinical Trials Manufacturing Agreement for Potential New Treatment for Levodopa Induced Dyskinesia
EMD Millipore Expands its EMPROVE® Raw Materials Portfolio to 400 Products
Modified Release Excipients
pH Modifier Excipients
Preservative Excipients
Solubilizer Excipients
Filler Excipients
Thickener Excipients
Hot Melt Extrusion Excipients
Film Former Excipients
Liquid Excipients
Lipid Excipients
An Interview With... Dr. Egmont G. Pfeifer and Dr. Albrecht Krämer of MEGGLE Group
Particle Engineering For Improved Bioavailability In Oral Solid Dose Medications
Almac Makes Further Significant co-investment to Meet Japanese Client Demand for Humidity Controlled Blister Packaging
Quotient Clinical Extends its Translational Pharmaceutics™ Platform into Cancer Drug Development
Taste Masking Techniques in the Pharmaceutical Industry
Forensics in QbD: Addressing Foreign Particulate Matter Investigations
Tergus Grows Manufacturing Capabilities Tergus Grows Manufacturing Capabilities
The New Dawn of Pharmaceutical Manufacturing: Innovative Solutions for Unprecedented Challenges
The Evaluation of Dual Laser Handheld Raman Spectroscopy for Identifying Novel Psychoactive Substances
Theory of Sampling (TOS) for Development of Spectroscopic Calibration Models
Crodasol HS HP
Solid State Considerations for Early Development
Utilizing a Novel Disperser Technology to Accelerate Sample Extraction of Pharmaceutical Solid Dosage Forms
“Joshi Capsules” US patent numbers – 8728521 and 9884024
API, Excipient, and Dosage Form Characterization Solutions for the Identity and Control of Critical Quality Attributes (CQA)
Expert Presentations at Australia Workshop on Powder Characterisation and Inhaler Testing
MEGGLE Appoints Barentz as its Exclusive Distributor of Pharmaceutical-Grade Lactose for United States
Are HPLC-UV Methods Fit for Purpose as True Arbiters of Quality for APIs?
Capsule Excipients
Ginkgo Bioworks Announces Collaboration with Merck to Improve API Manufacturing
Elemental Impurities: Implications for Manufacturers of Drug Products, APIs, and Excipients
DFE Pharma Expands Co-Processed Portfolio
The KEY TO Pharma’s Next Generation Success
CPhI Worldwide 2013 Hosted More Than 34,000 Global Pharma Professionals with Expanded Content and First Annual Report
Merck KGaA: Allergopharma Plans to Invest € 40 Million in Production Facility
Vetter Launches New Clinical Syringe Packages
A Recent Advancement in Orally Disintegrating Formulations
Future of Transdermal Drug Delivery Systems (TDDS)
Rapid Detection of Counterfeit Drugs of Ethambutol Hydrochloride and Cefuroxime Axetil using Handheld Raman, Near Infrared and Portable FTIR Technologies
Colorcon, Inc. Launches First Certified Organic Coating System for Dietary Supplement Tablets
Automated and Rapid Methods to Assess Quality & Stability of Biologics: Recent Developments and Practical Ways to Implement Them in Formulation Development
An Interview With Andreas Gryczke, Global Technical Marketing Solubilization BASF Pharma Solutions
Investigation of Excipient Compatibility and Associated Degradations for the Formulation Development of a Small Molecule Pharmaceutical Compound
Ashland Injectable Excipient Accepted Into FDA Novel Excipient Review Program
Key Considerations for Stabilizing Oxidation-Prone Lipid-Based Drug Delivery Systems
BASF pharmaceutical solutions presented at CPhI Worldwide in Frankfurt, Germany
Drug Delivery Roundtable
ABITEC Improves Solubility of Topical, Transdermal Applications with Functional Lipid Excipients
Raw Materials and Functional Excipients Roundtable
Valneva and IDT Biologika Terminate their COVID-19 Collaboration
Fraunhofer IZI Selects Lonza’s MODA-ES Solution to Digitalize Manufacturing Operations
New Pancreatic Cancer Drug Receives Orphan Drug Designation by FDA
CURE Pharmaceutical Debuts CUREform Drug Delivery Line
Benefits of Using High-Functionality Excipients in a Continuous Manufacturing Process
Roquette Acquires Qualicaps
Recent Innovations in Pharmaceutical Hot Melt Extrusion
Johnson & Johnson Appoints Senior Leaders to Executive Committee
ReForm Biologics, MilliporeSigma Announce Licensing Agreement
Lubrizol Licenses Apisolex Excipient to Welton Pharmaceuticals to Develop Novel Cancer Therapeutic
Pharmaceutical P.I.N. Points: Patent Innovation News
Antibody-Drug Conjugates (ADCs): Potent Cancer Killers with PK Challenges
Reader Quiz: Drug Development Challenges
VITAMIN C – Tableting with LUBRITAB® RBW Lubricant
Vibrational Spectroscopy for the Analysis of Dissolved Active Pharmaceutical Ingredients
Nanoparticle Technologies: Enablers for Ocular Drug Delivery
CPhI Japan Postponed
Pharmaceutical PIN Points
Subscriptions
Get started here for your complimentary print or digital subscription
Sign up Now »
Excipients
Clear
Search By
Keywords
Dosage Form
Process
Apply Changes
Blending
Capsule Filling
Cell Culture
Chelation
Compaction
Direct Compression
Dry Blending
Dry Compression
Dry Granulation
Extrusion
Extrusion spheronisation
Film Coating
Film Formation
Freeze Drying
Hot Melt Extrusion
Injectable Formulation
Melt Coating
Melt Congealing
Melt Spraying
Molecular Encapsulation
Protein Stabilization
Roller Compaction
Sachet Filling
SMEDDS
Solid Lipid Nanoparticles
Solubilization
Spheronization
Spray Congealing
Spray Drying
Supercritical Fluid Extraction
Viscosity Modification
Wet Granulation
Functionality
Apply Changes
Acidifier
Active Pharmaceutical Ingredient
Adhesive
Anti-adherant
Binder
Blending
Capsule Filling
Capsule Shell
Carrier
Cell Culture Ingredient
Co-processed
Coating Systems
Compaction
Controlled Release
Crystallization Inhibitor
Diluent
Direct Compression
Disintegrant
Dispersion
Dry Granulation
Dry Powder Inhalation
Effervescent System
Emulsifier
Extended Drug Release
Filler
Film Formation
Film Former
Flavor
Flow Aid
Freeze Drying
Gastrointestinal Dispersion
Granulation
High-Functionality
Hot Melt Extrusion
Increased Bioavailability
Isotonic Agent
Lipid
Lubricant
Mechanical strength
Modified Release
Multifunctional
Natural Origin
Nutritional Agent
Penetration Enhancer
Permeation Enhancer
pH Modifier
pH regulation
Pigment
Plasticizer
Powder Blends
Preservative
Rapid Release Agent
Sachet Filling
Solubility Enhancement
Solubilizer
Solvent
Spray Drying
Stabilizer
Surfactant
Sustained Release
Sweetener
Tablet Compressibility
Tablet Ejection
Targeted Delivery
Taste Masking
Therapeutic Agent
Thickener
Viscosity Modifier
Wet Binder
Wet Granulation
Dosage Form
Apply Changes
Film
Implant
Liquid
Multiple Dosage Forms
Parenteral
Pulmonary
Semi-solid
Suppository
Tablet
Transdermal
Companies
Apply Changes
Gattefossé
Featured Products
PURELAB® Chorus 1 Complete Ultrapure Water System
Labrasol® ALF
Maisine® CC
Connect with Us